SEC Form 4 · accession 0001232524-17-000142
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Heather Ann McSharry
Director
Period of report
Aug 10, 2017
Accepted (ET)
Aug 14, 2017 · 5:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Aug 10, 2017 | A | 1,365 | $0.00 | A | 7,441 | D | |
| Ordinary Shares | Aug 11, 2017 | S | 714 | $142.36 | D | 6,727 | D | |
| Ordinary Shares | Aug 11, 2017 | S | 3 | $144.1254 | D | 6,724 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F3 | $143.66 | Aug 10, 2017 | A | 3,415 | A | — | Aug 9, 2027 | Ordinary Shares | 3,415 | 3,415 | D |
Explanation of responses
- F1These restricted stock units are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2018.
- F2Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- F3These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in 12 equal monthly installments beginning on September 1, 2017.